EXACTECH TOTAL HIP SYSTME: 22MM FEMORAL HEAD

K964262 · Exactech, Inc. · JDI · Dec 27, 1996 · Orthopedic

Device Facts

Record IDK964262
Device NameEXACTECH TOTAL HIP SYSTME: 22MM FEMORAL HEAD
ApplicantExactech, Inc.
Product CodeJDI · Orthopedic
Decision DateDec 27, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3350
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Exactech Total Hip System: 22mm Femoral Head is indicated for use in skeletally mature individuals undergoing primary surgery for total hip replacement due to osteoarthritis, osteonecrosis, congenital hip dysplasia, rheumatoid arthritis and/or post-traumatic degenerative problems. It is also potentially indicated for revision of failed previous reconstructions where sufficient bone stock is present.

Device Story

The Exactech 22mm Femoral Head is a prosthetic component for total hip arthroplasty. It is a cobalt chromium alloy head available in three neck lengths (-3mm, +2mm, +8mm) and a 22mm diameter. The device is implanted by an orthopedic surgeon during hip replacement surgery. It mates with a femoral stem via an internal taper lock and articulates against an acetabular component (typically UHMWPE). The device restores hip joint function in patients with degenerative joint disease or failed prior reconstructions. Clinical benefit is derived from the established biocompatibility and mechanical performance of cobalt chromium alloys in orthopedic bearing applications.

Clinical Evidence

No clinical data provided for this specific device. Evidence relies on historical clinical literature (Charnley et al., 1973, 1975; Mirra et al., 1976) and laboratory biocompatibility studies (Turner et al., 1973) demonstrating the safety and performance of cobalt chromium alloys in orthopedic applications.

Technological Characteristics

Material: Wrought high strength cobalt chromium (ASTM F90-87). Design: 22mm diameter, three neck lengths (-3mm, +2mm, +8mm). Interface: Internal taper lock for femoral stem connection. Sterilization: Gamma irradiation (SAL 10^-6) per AAMI guidelines.

Indications for Use

Indicated for skeletally mature patients undergoing primary total hip replacement for osteoarthritis, osteonecrosis, congenital hip dysplasia, rheumatoid arthritis, or post-traumatic degeneration; also for revision of failed reconstructions with sufficient bone stock. Contraindicated in patients with active infection, insufficient bone stock, neuromuscular disorders preventing hip control, or patients with weight, age, or activity levels expected to cause early system failure.

Regulatory Classification

Identification

A hip joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene and is limited to those prostheses intended for use with bone cement (§ 888.3027).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} K964262 006 DEC 27 1996 # 510(K) Summary ## SUMMARY OF THE SAFETY AND EFFECTIVENESS INFORMATION IN THE PREMARKET NOTIFICATION FOR THE EXACTECH TOTAL HIP SYSTEM: 22mm FEMORAL HEAD Exactech, Inc. Establishment Registration Number 1038671 The Exactech 22mm Femoral Head is made of similar materials and is of a similar design to prostheses that were on the market before May 28, 1976. Additionally, the 22mm Femoral Head is of similar design to other components on the market that have been determined to be equivalent to devices on the market prior to May 28, 1976. These predicates include, but are not limited to: - Orthomet - Zimmer-Charnley Type Total Hip - Exactech® Femoral Heads In addition, Exactech provided to the FDA, design drawings, and material specifications characterizing the 22mm Femoral Head The Food and Drug Administration, in rules listed in the Federal Register, Friday, September 4, 1987, as Hip Joint Metal/Polymer Semi-Constrained Prosthesis, Section 888.3350 and Docket No. 78N3075, as a class II Device. ## Design Considerations The Exactech 22mm Femoral Head is sized in three neck lengths: short (-3mm), standard (+2mm), long (+8mm). It is available in 22mm diameter. The femoral head is made of cobalt chromium alloy, a preferred metal alloy for bearing with The Ultra High Molecular Weight Polyethylene (UHMWPE), found in the acetabular components. The femoral head mates with the femoral stem by its precise internal taper lock. In addition, its overall design is similar to those used by Charnley and others since the early introduction of Total Hip Arthroplasty and assures adequate component thickness as put forth by Bartel for such components. ## Design Parameters The Exactech Total Hip System: 22mm Femoral Head consists of various neck lengths and is made from forged high strength cobalt chromium. The components are available in a range of sizes to fit varying anatomical requirements. The device is designed for use with all Exactech femoral components. A complete trial set and instrumentation is available to assist in accurate implantation of the prosthetic components. Design drawings are typical for such components that have been used in the industry since their introduction by Charnley in the late '60's. {1} K 964262 007 ## Material Specifications The Exactech 22mm Femoral Head is manufactured from wrought high strength cobalt chromium corresponding with ASTM F90-87. ## Biocompatibility Cobalt Chromium has a long history of use in orthopaedic applications. Its biological response has been well characterized by a history of clinical studies (Charnley, J., Cupiz, A., “The Nine and Ten Year Results of the Low Friction Arthroplasty of the Hip”, Clinical Orthopaedics, Vol 95, No. 9, 1973.; Halley, D., Charnley, J. “Results of Low Friction Arthroplasty in Patients 30 Years of Age and Younger”, Clinical Orthopaedics, No. 112, October, 1975 and Mirra, J., Amstutz, H., Matos, M., and Gold, R., “The Pathology of Joint Tissues and Its Clinical Relevance in Prosthesis Failure”, Clinical Orthopaedics, No. 117, June, 1976) and by laboratory studies (Turner, J., Lawrence, W., and Autian, J., “Subacute Toxicity Testing of Biomaterials Using Histopathologic Evaluation of Rabbit Muscle Tissue,” Journal of Biomedical Materials Research, Vol 7, 1973. Compatibility of Biocompatibility of Materials for Total Joint Replacement”. Journal of Biomed. Mater. Research, Vol 10, No.2, 1976.). These tests include data on human and animal performance and show that the tissue exhibits excellent biocompatibility. See Volume II for References ## Sterilization The Exactech 22mm Femoral Head will be sterilized by gamma irradiation. The Sterility Assurance Level (SAL) is $10^{-6}$. Exactech utilizes Method 3, Protocol B from the “AAMI Guideline for gamma radiation sterilization” for the sterility dose setting and validation procedure. ## Utilization and Implantation Selection of the Exactech Total Hip System: 22mm Femoral Head depends on the judgement of the surgeon in relationship to the requirements of the patient. The surgeon should become thoroughly familiar with the technique of implantation by appropriate reading of the literature, and training in the operative skills and techniques required for total hip arthroplasty surgery. ## Indications The Exactech Total Hip System: 22mm Femoral Head is indicated for use in skeletally mature individuals undergoing primary surgery for total hip replacement due to osteoarthritis, osteonecrosis, congenital hip dysplasia, rheumatoid arthritis and/or post-traumatic degenerative problems. It is also potentially indicated for revision of failed previous reconstructions where sufficient bone stock is present. {2} K 96426 008 ## Contraindications Use of the Exactech 22mm Femoral Head is contraindicated in patients with active infection, patients without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis, in neuromuscular disorders that do not allow control of the hip joint, and in patients whose weight, age, or activity level would cause the surgeon to expect early failure to the system.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...